These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12647690)

  • 1. FDA notifications. Watch out for counterfeit Procrit, 2 lot numbers.
    AIDS Alert; 2002 Aug; 17(8):101-2. PubMed ID: 12647690
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. Watch for counterfeit lot of Serostim.
    AIDS Alert; 2002 Aug; 17(8):102. PubMed ID: 12647692
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA warns about counterfeit Epogen.
    AIDS Alert; 2002 Aug; 17(8):102-3. PubMed ID: 12647693
    [No Abstract]   [Full Text] [Related]  

  • 4. Warning, counterfeit Procrit (epoetin alfa).
    AIDS Treat News; 2003 Mar; (389):8. PubMed ID: 12712940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA notifications. FDA uncovers counterfeit Procrit.
    AIDS Alert; 2003 Jun; 18(6):79-80. PubMed ID: 12866479
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA warns about counterfeit drug.
    AIDS Patient Care STDS; 2003 May; 17(5):258. PubMed ID: 12825589
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. FDA revises Baraclude labeling for HIV patients.
    AIDS Alert; 2007 Sep; 22(9):103-4. PubMed ID: 18415955
    [No Abstract]   [Full Text] [Related]  

  • 8. Counterfeit Procrit.
    FDA Consum; 2003; 37(3):5. PubMed ID: 12793379
    [No Abstract]   [Full Text] [Related]  

  • 9. Counterfeit version of Serostim investigated by FDA.
    Posit Living; 2001 Feb; 10(2):10. PubMed ID: 11548491
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approves Epoetin Alfa use for AZT patients.
    Nephrol News Issues; 1991 Apr; 5(4):11. PubMed ID: 1961277
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. Updates made to Reyataz package insert.
    AIDS Alert; 2008 Oct; 23(10):116-7. PubMed ID: 18935687
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. FDA approves label change for nevirapine.
    AIDS Alert; 2008 Aug; 23(8):91-2. PubMed ID: 18724490
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. Revised atazanavir package insert.
    AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. Lopinavir/ritonavir label updated.
    AIDS Alert; 2008 Aug; 23(8):92. PubMed ID: 18727173
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Raltegravir indication extended for treatment-naive patients.
    AIDS Alert; 2009 Aug; 24(8):93. PubMed ID: 19705587
    [No Abstract]   [Full Text] [Related]  

  • 16. Anemia in the setting of cancer and human immunodeficiency virus.
    Levine AM
    Clin Infect Dis; 2003; 37 Suppl 4():S304-14. PubMed ID: 14581999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA notifications. Changes to ART guidelines detailed by the FDA.
    AIDS Alert; 2008 Mar; 23(3):33-4. PubMed ID: 18663777
    [No Abstract]   [Full Text] [Related]  

  • 18. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
    Hayslip D
    Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of anemia in human immunodeficiency virus, cancer, and hepatitis C virus.
    Mildvan D
    Clin Infect Dis; 2003; 37 Suppl 4():S293-6. PubMed ID: 14581997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danger: counterfeit Serostim (human growth hormone).
    AIDS Treat News; 2001 May; (365):5. PubMed ID: 11547414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.